What’s next for lab-grown human embryos?
By Kendall Powell,
Nature
| 08. 31. 2021
It was day 13 in a set of experiments in Ali Brivanlou’s laboratory and he had an agonizing task ahead. His team of developmental biologists had thawed dozens of human embryos, placed them into individual culture dishes and watched them grow through the earliest stages of development — something that only a handful of researchers worldwide had ever seen. But he knew that it had to end.
The embryos would soon bump up against the 14-day rule, an international consensus that human embryos should be cultured and grown in the lab only until 14 days post-fertilization. Day 14 is roughly when the primitive streak appears, a structure that marks the point at which the embryo sets up the body axes, and begins to distinguish head from tail and left from right.
“It was one of the toughest decisions I’ve had to make in my life, but it was time to stop this experiment,” says Brivanlou, recalling the 2015 research in his lab at the Rockefeller University in New York City. On day 13, the team peeled the embryos from the...
Related Articles
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
Image by Mohamed Hassan from Pixabay
It is hard to make predictions, especially about the future, as Yogi Berra, Niels Bohr, and other luminaries have remarked. But there are already signs that the incoming Trump administration may have some difficulty establishing consistent policies about controversial issues concerning human reproduction.
On the one hand, consider “the conservative blueprint for a second Trump administration.”
The notorious Project 2025’s Mandate for Leadership seeks to delete terms such as “reproductive rights” from “every federal...
By Susan Dominus, The New York Times | 11.30.2024
In the days after Daphna Cardinale delivered her second child, she experienced a rare sense of calm and wonder. The feeling was a relief after so much worrying: She and her husband, Alexander, had tried for three years to conceive...
By Christy Santhosh, Reuters | 11.27.2024
Nov 27 (Reuters) - The U.S. Food and Drug Administration is weighing the need for regulatory action on bluebird bio's (BLUE.O), opens new tab gene therapy for a rare neurological disorder, it said on Wednesday, as the agency probes additional...